Esquire director reports 30,000-share stock sale

Esquire Financial Holdings director Selig Zises reported net open-market sales of 30,000 shares of common stock.

Rhea-AI Filing Summary

Esquire Financial Holdings director Selig Zises reported net open-market sales of 30,000 shares of common stock. The transactions on March 18–19, 2026 were executed through indirect accounts, including a profit sharing plan and a trust, at prices around $105–$107 per share.

After these sales, reported indirect holdings include 6,501 shares in the profit sharing plan and 63,533 shares held by a trust, along with 15,716 shares held directly. Some reported holdings include restricted stock that will vest over future dates.

Insider Trade Summary

Net Seller: 30,000 shares

Net Sell 15 txns

Insider ZISES SELIG

Role Director

Sold 30,000 shs ($3.19M)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,000	$105.25	$211K
Sale	Common Stock	3,000	$105.00	$315K
Sale	Common Stock	8,500	$107.00	$910K
Sale	Common Stock	2,000	$105.535	$211K
Sale	Common Stock	2,000	$106.0431	$212K
Sale	Common Stock	1,500	$105.1147	$158K
Sale	Common Stock	2,000	$105.1636	$210K
Sale	Common Stock	1,500	$106.0801	$159K
Sale	Common Stock	1,500	$107.01	$161K
Sale	Common Stock	2,000	$107.1251	$214K
Sale	Common Stock	3,000	$107.25	$322K
Sale	Common Stock	1,000	$107.2554	$107K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 6,501 shares (Indirect, By profit sharing plan); Common Stock — 63,533 shares (Indirect, By Trust); Common Stock — 15,716 shares (Direct); Common Stock — 25,500 shares (Indirect, As trustee for trust); Common Stock — 12,600 shares (Indirect, By L.P.)

Footnotes (6)

1. F1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
2. F2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
3. F3. Includes shares of restricted stock which vest 100% on December 10, 2026.
4. F4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
5. F5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
6. F6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Esquire Financial (ESQ) disclose in this Form 4?

The Form 4 shows director Selig Zises reported open-market sales of 30,000 shares of Esquire Financial common stock. The trades occurred on March 18–19, 2026 through indirect accounts at prices around $105–$107 per share.

At what prices were the Esquire Financial (ESQ) shares sold by entities linked to the director?

The reported sales were executed at prices between $105.00 and $107.25 per share. Each transaction involved blocks of 1,000–8,500 shares of Esquire Financial common stock in open-market or private transactions classified as sales.

How many Esquire Financial (ESQ) shares did the director’s profit sharing plan sell?

The profit sharing plan associated with director Selig Zises sold several blocks totaling 14,500 shares. After these transactions, that plan’s reported indirect holdings in Esquire Financial common stock stand at 6,501 shares as of the reported date.

How many Esquire Financial (ESQ) shares did the trust linked to the director sell?

A trust associated with director Selig Zises reported selling 15,500 shares of Esquire Financial common stock across multiple trades. Following these sales, the trust’s reported indirect holdings total 63,533 shares according to the filing data.

What are the director’s remaining reported holdings in Esquire Financial (ESQ) after these sales?

After the reported sales, Selig Zises shows 15,716 shares held directly, plus indirect holdings including 6,501 shares in a profit sharing plan and 63,533 shares in a trust. Additional indirect positions are reported through other entities.

Does the Esquire Financial (ESQ) Form 4 mention restricted stock for the director?

Yes. Footnotes state the reported holdings include restricted stock awards that vest over several years. These grants vest either in three equal annual installments or 100% on specific future December dates between 2024 and 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/20/2026 - 03:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZISES SELIG

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NEW YORK 11753

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		8,500	D	$107	12,501	I	By profit sharing plan
Common Stock	03/18/2026		S		2,000	D	$105.535	10,501	I	By profit sharing plan
Common Stock	03/18/2026		S		2,000	D	$106.0431	8,501	I	By profit sharing plan
Common Stock	03/19/2026		S		2,000	D	$105.25	6,501	I	By profit sharing plan
Common Stock	03/18/2026		S		1,500	D	$105.1147	77,533	I	By Trust
Common Stock	03/18/2026		S		2,000	D	$105.1636	75,533	I	By Trust
Common Stock	03/18/2026		S		1,500	D	$106.0801	74,033	I	By Trust
Common Stock	03/18/2026		S		1,500	D	$107.01	72,533	I	By Trust
Common Stock	03/18/2026		S		2,000	D	$107.1251	70,533	I	By Trust
Common Stock	03/18/2026		S		3,000	D	$107.25	67,533	I	By Trust
Common Stock	03/18/2026		S		1,000	D	$107.2554	66,533	I	By Trust
Common Stock	03/19/2026		S		3,000	D	$105	63,533	I	By Trust
Common Stock								15,716(1)(2)(3)(4)(5)(6)	D
Common Stock								25,500	I	As trustee for trust
Common Stock								12,600	I	By L.P.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

3. Includes shares of restricted stock which vest 100% on December 10, 2026.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

	/s/ Eric S. Bader, pursuant to power of attorney	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)